ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome (H-REPLACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03363035
Recruitment Status : Recruiting
First Posted : December 5, 2017
Last Update Posted : July 3, 2018
Sponsor:
Information provided by (Responsible Party):
Shenghua Zhou, Second Xiangya Hospital of Central South University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2019
  Estimated Study Completion Date : May 31, 2020